Scientists stopped the progression of Duchenne muscular dystrophy using the CRISPR/Cas9 method of gene editing, according to a new study. "This is different from other therapeutic approaches, because it eliminates the cause of the disease," said Dr. Eric Olson, chair of the department of molecular biology at the University of Texas Southwestern Medical Center, in a press release.
Researchers sent gene-editing components to cells in mice using the adeno-associated virus 9, and the rodents started producing dystrophin and showing improvement to skeletal muscle and the heart.
Read the rest of the story HERE:
At www.upi.com
At www.upi.com
1
1
1
